Desai Antal Rohit 4
4 · PROCEPT BioRobotics Corp · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Desai Antal Rohit
Director
Transactions
- Sale
Common Stock
2025-06-10$64.02/sh−18,412$1,178,683→ 66,089 total(indirect: By Trust) - Sale
Common Stock
2025-06-10$64.67/sh−1,726$111,625→ 64,363 total(indirect: By Trust) - Award
Common Stock
2025-06-10+1,538→ 8,403 total - Sale
Common Stock
2025-06-11$64.27/sh−5,717$367,447→ 39,363 total(indirect: By Trust) - Sale
Common Stock
2025-06-12$62.33/sh−5,049$314,693→ 14,363 total(indirect: By Trust) - Sale
Common Stock
2025-06-10$63.23/sh−4,862$307,403→ 84,501 total(indirect: By Trust) - Sale
Common Stock
2025-06-11$62.59/sh−7,788$487,476→ 56,575 total(indirect: By Trust) - Sale
Common Stock
2025-06-11$63.47/sh−11,495$729,603→ 45,080 total(indirect: By Trust) - Sale
Common Stock
2025-06-12$61.28/sh−19,951$1,222,563→ 19,412 total(indirect: By Trust) - Award
Stock Option (Right to Buy)
2025-06-10+2,771→ 2,771 totalExercise: $64.23Exp: 2035-06-09→ Common Stock (2,771 underlying)
Footnotes (11)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.89 to $62.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F11]The Stock Option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.56 to $63.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.56 to $64.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.56 to $64.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.08 to $63.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.08 to $64.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.08 to $64.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.89 to $61.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.